Spaceflight is hard on the heart, yet artificial ones grow better in space than on Earth – Image for illustrative purposes only (Image credits: Unsplash)
Astronauts venturing into space face a harsh reality for their cardiovascular systems. Prolonged exposure to microgravity causes human hearts to atrophy, even among those who maintain rigorous exercise routines. Yet, in the same weightless environment, laboratory-grown mini-hearts derived from stem cells develop more rapidly than their Earth-bound counterparts. This striking contrast, drawn from multiple space-based experiments, underscores the complex interplay between human physiology and orbital conditions.[1][2]
Astronaut Hearts Adapt by Shrinking
Researchers have long observed that spaceflight takes a toll on the heart. During extended missions aboard the International Space Station, astronauts experience reduced blood volume and diminished gravitational pull, prompting structural changes in cardiac tissue. A detailed study of former NASA astronaut Scott Kelly revealed significant atrophy after his 340-day stay from March 2015 to March 2016. Despite exercising nearly every day with cycling, treadmill sessions, and resistance training, Kelly’s left ventricle lost an average of 0.74 grams of mass each week – equivalent to about a tenth of an ounce over time.[1]
The heart’s left ventricle, responsible for pumping oxygenated blood throughout the body, initially decreased in diastolic diameter as it relaxed to fill with blood. Function remained adequate upon return, but the organ had remodeled itself into a more spherical shape to cope with microgravity. UT Southwestern Medical Center scientists, led by Benjamin D. Levine, published these findings in the journal Circulation in 2021. Levine, who has tracked space travel’s cardiac impacts since the late 1980s, noted that fitter astronauts tend to lose more muscle mass in orbit compared to less conditioned individuals.[1]
Stem Cell Mini-Hearts Thrive in Orbit
In contrast, artificial heart models flourish under the same conditions. Scientists transformed pluripotent stem cells into beating cardiac muscle cells aboard the International Space Station, achieving results faster than in terrestrial labs. An experiment during NASA’s SpaceX-20 mission demonstrated that these immature cells differentiated into functional heart tissue within just three weeks in microgravity. Ground simulations had hinted at this acceleration, but orbital confirmation solidified the advantage.[2]
Emory University researchers Chunhui Xu and Kevin Maher spearheaded the effort, partnering with NASA. The cells, once matured, exhibited robust beating patterns upon analysis back on Earth. “We were hoping to identify a more effective way to generate these cells by exploring the use of microgravity,” Xu stated. This rapid development offers a pathway to producing larger quantities of heart cells for treating conditions in children and adults alike.[2]
Unpacking the Experiments and Methods
Creating these mini-hearts begins with pluripotent stem cells, versatile building blocks capable of becoming nearly any cell type. In space, researchers directed differentiation by exposing the cells to specific growth media over controlled periods. The process yielded three-dimensional organoids mimicking heart chambers, complete with organized cell types like cardiomyocytes. No sterile lab beyond basic equipment proved necessary, making the technique scalable.[3]
Heart atrophy studies, meanwhile, relied on pre- and post-flight imaging, such as echocardiograms and MRIs, to quantify changes. Kelly’s case paralleled findings from other astronauts and even extreme endurance athletes like swimmer Benoit Lecomte, who lost similar ventricular mass during a 159-day Pacific crossing. These comparisons highlight how reduced workload in low-gravity mimics prolonged bed rest or ultra-endurance efforts on Earth. Microgravity studies continue to inform countermeasures for future Mars missions.[1]
Key Contrasts in Microgravity:
- Human Hearts: Atrophy at 0.74g/week; spherical remodeling; good function post-flight.
- Stem Cell Organoids: Differentiate in 3 weeks; faster proliferation; enhanced beating.
Pathways to Medicine and Deep Space Travel
The duality presents opportunities for both astronaut health and regenerative therapies. Faster organoid growth could enable personalized heart patches or valves, tested directly from patient cells. Space-derived insights might reveal why microgravity boosts stem cell efficiency, potentially translating to Earth-based bioreactors. Meanwhile, understanding atrophy drives development of advanced exercise protocols or pharmacological aids to preserve cardiac mass.
Institutions like the National Heart, Lung, and Blood Institute emphasize mini-hearts’ role in modeling diseases without animal intermediaries. Ongoing missions to the ISS carry more cardiac tissue samples, probing aging, stress responses, and repair mechanisms. As humanity eyes longer voyages, resolving this paradox could safeguard crews while revolutionizing cardiac repair. Researchers anticipate breakthroughs that bridge orbital oddities with everyday medicine.